Yintoni omele uyenze ukuba awunciphisi ubunzima kwiyeza le-GLP-1?
Okubalulekileyo, umonde ubalulekile xa uthatha iyeza le-GLP-1 njenge-semaglutide.
Ngokufanelekileyo, kuthatha ubuncinane iiveki ezili-12 ukubona iziphumo.
Nangona kunjalo, ukuba awuboni ukwehla kobunzima ngelo xesha okanye unenkxalabo, nantsi ezinye iindlela onokuthi uziqwalasele.
Thetha nogqirha wakho
Iingcali zigxininisa ukubaluleka kokuba nencoko nogqirha wakho, nokuba ulahlekelwa bubunzima okanye hayi.
Kubalulekile ukufuna isikhokelo kugqirha wakho, onokuthi avavanye izinto ezichaphazela ukusebenza kakuhle kwaye acebise uhlengahlengiso oluyimfuneko, njengokutshintsha idosi okanye ukuhlola olunye unyango.
Iingcali zithi kufuneka udibane nogqirha wakho ubuncinane kanye ngenyanga, rhoqo xa idosi yesigulana sakho sonyuswa kwaye ukuba bafumana iziphumo ebezingalindelekanga ezibalulekileyo.
Uhlengahlengiso kwindlela yokuphila
Imikhwa yokutya: Cebisa izigulana ukuba ziyeke ukutya xa zihluthi, zitye ubukhulu becala, ukutya okungalungiswanga, kwaye ziziphekele izidlo zazo kunokuba zixhomekeke ekuthatheni okanye kwiinkonzo zokuhambisa.
Ukufakwa kwamanzi: Khuthaza izigulane ukuba ziqinisekise ukuba zisela amanzi aneleyo yonke imihla.
Umgangatho wokulala: Kucetyiswa ukuba ulale iiyure ezisi-7 ukuya kwezisi-8 ubusuku ngabunye ukuxhasa ukuchacha nokulawula ubunzima bomzimba.
Imikhwa yokuzilolonga: Gxininisa ukubaluleka kokuzilolonga rhoqo ukugcina impilo entle nokukhuthaza ukulawula ubunzima.
Imiba yeemvakalelo kunye nezengqondo: Bonisa ukuba uxinzelelo kunye nemiba yeemvakalelo inokuchaphazela indlela yokutya kunye nomgangatho wokulala, ngoko ukujongana nale miba kubalulekile kwimpilo yonke kunye nenkqubela yokulawula ubunzima.
Lawula iziphumo ebezingalindelekanga
Iziphumo ebezingalindelekanga ziya kunyamalala ngokuhamba kwexesha. Iingcali zithi abantu banokuthatha amanyathelo okukhululeka kwaye balawule, kubandakanya:
Yitya ukutya okuncinci kwaye rhoqo.
Kuphephe ukutya okunamafutha, okuhlala esiswini ixesha elide kwaye kunokwenza iingxaki zesisu ezifana nesicaphucaphu kunye ne-reflux ibe mandundu.
Thetha nogqirha wakho malunga ne-counter-the-counter kunye namayeza amiselweyo anokukunceda ukuba wenze iziphumo ezichaphazelekayo zilawuleke, kodwa zinokuba zexesha elifutshane.
Tshintshela kwelinye iyeza
I-Semaglutide ayilona khetho kuphela abantu abanalo. I-Telport yamkelwa ngo-2023 ukunyanga ukutyeba kunye nokutyeba kakhulu kunye neemeko ezithile zonyango eziphantsi.
Ulingo luka-2023 lubonise ukuba abantu abatyebe kakhulu okanye abatyebe kakhulu kodwa abangenaso isifo seswekile baphulukene nomndilili we-21% yobunzima bomzimba wabo kwiiveki ezingama-36.
I-Semaglutide, njenge-GLP-1 i-receptor agonist, ilinganisa i-hormone ye-GLP-1, ukunciphisa ukutya ngokunyusa i-insulin secretion kunye nokubonisa ukuhlutha kwengqondo. Ngokwahlukileyo, i-tepoxetine isebenza njenge-agonist emibini ye-glucose-exhomekeke kwi-insulinotropic polypeptide (GIP) kunye ne-GLP-1 receptors, ekhuthaza ukukhutshwa kwe-insulin kunye nokuhlutha. (Zombini i-GIP kunye ne-GLP-1 i-agonists ziihomoni eziveliswa ngokwemvelo kwinkqubo yethu yesisu.)
Iingcali zithi abanye abantu banokuba nemiphumo engcono yokulahlekelwa kwesisindo kunye ne-tepoxetine, kubandakanywa nalabo abangaphenduliyo kwi-semaglutide.
Ixesha lokuposa: Apr-18-2025